Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

590 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Endothelial dysfunction of peripheral arteries in patients with immunohistologically confirmed myocardial inflammation correlates with endothelial expression of human leukocyte antigens and adhesion molecules in myocardial biopsies.
Vallbracht KB, Schwimmbeck PL, Seeberg B, Kühl U, Schultheiss HP. Vallbracht KB, et al. Among authors: schultheiss hp. J Am Coll Cardiol. 2002 Aug 7;40(3):515-20. doi: 10.1016/s0735-1097(02)01990-3. J Am Coll Cardiol. 2002. PMID: 12142120 Free article.
Diagnostic endomyocardial biopsy interpretation.
Noutsias M, Pauschinger M, Kuhl U, Schultheiss HP. Noutsias M, et al. Among authors: schultheiss hp. Can J Cardiol. 2003 Jan;19(1):98-9; author reply 99-100. Can J Cardiol. 2003. PMID: 12577906 No abstract available.
Induction of coxsackievirus-adenovirus-receptor expression during myocardial tissue formation and remodeling: identification of a cell-to-cell contact-dependent regulatory mechanism.
Fechner H, Noutsias M, Tschoepe C, Hinze K, Wang X, Escher F, Pauschinger M, Dekkers D, Vetter R, Paul M, Lamers J, Schultheiss HP, Poller W. Fechner H, et al. Among authors: schultheiss hp. Circulation. 2003 Feb 18;107(6):876-82. doi: 10.1161/01.cir.0000050150.27478.c5. Circulation. 2003. PMID: 12591759
Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction.
Kühl U, Pauschinger M, Schwimmbeck PL, Seeberg B, Lober C, Noutsias M, Poller W, Schultheiss HP. Kühl U, et al. Among authors: schultheiss hp. Circulation. 2003 Jun 10;107(22):2793-8. doi: 10.1161/01.CIR.0000072766.67150.51. Epub 2003 May 27. Circulation. 2003. PMID: 12771005 Clinical Trial.
590 results